A recent article spotlights important questions about antidepressant use in children. Analyses suggest limited benefit in certain cases, while prescribing rates continue to rise. Other findings highlight the need for careful monitoring and greater awareness of potential risks—especially with longer-term use.

These concerns underscore a broader issue: how we understand and respond to childhood distress. Children and families deserve a full range of support, including evidence-based therapies and non-drug approaches.

The goal is not to dismiss treatment, but to ensure it is measured, informed, and centered on the child.Read the full article at https://www.madinamerica.com/2026/04/questioning-the-prescription-antidepressants-and-the-medicalization-of-childhood/.